40 Pakistani companies to participate in the Arab Health Expo in Dubai

About 40 Pakistani companies are currently participating in the 4 day Arab Health Expo 2024 exhibition held at the Dubai World Trade Centre.

Hussain Mohammed, Consul General of the Pakistani Consulate in Dubai, expressed his happiness at the large number of Pakistani exhibitors participating in the first exhibition.

The annual exhibition is scheduled to conclude on February 1. It is worth noting that the Arab Health Exhibition is one of the largest healthcare exhibitions in the region, with more than 3,000 exhibitors participating. Investors, professionals and educators from more than 150 countries are participating in this event.

After the opening of the Pakistani pavilion, Hussein Muhammad stressed its importance. He added that it provides profitable investment opportunities and serves as a platform to address global healthcare challenges.

“The event will provide Pakistani companies with the opportunity to diversify their exports, explore new markets and network with industry leaders from around the world,” he added.

The Consul General emphasized that with the support of the government through Trade Development Authority of Pakistan (TDAP), exhibitors are presenting pharmaceutical products, surgical materials and hospital textiles at the exhibition.

“Several side events and workshops are also scheduled to be organized during the four-day event, which will provide good exposure to our companies,” he said.


You might be interested in:

Aga Khan University Hospital and AKHS Hospitals First in Pakistan To Receive SafeCare Certification

The Aga Khan Hospital for Women in Karimabad, Karachi and Aga Khan Maternal and Child Care Centre in Hyderabad, part of the Aga Khan University Hospitals (AKUH) network; and Aga Khan Medical Centre in Gilgit, part of the Aga Khan Health Services (AKHS) network, are the first hospitals in Pakistan to receive Level 5 SafeCare certification.

An initiative of Pharm Access, Joint Commission International (JCI), and Council for Health Service Accreditation of Southern Africa (COHSASA), SafeCare is a methodology with international accredited standards, aiming to improve quality care in low- and middle-income countries, where 3.6 million people die every year because of low quality care. Level 5 status is given to institutions that demonstrate high-quality standards across the SafeCare Service Elements.

“SafeCare certification is an endorsement that a health facility has met certain internationally recognized quality and safety standards for patient care,” said Dr Farhat Abbas, interim Chief Executive Officer of Aga Khan University (AKU) Health Services in Pakistan. “In addition to the SafeCare certification, AKUH is also accredited by JCI, and its clinical laboratories are accredited by the College of American Pathologists for fast and accurate testing. These accreditations are a true testament to the high-quality of healthcare and patient safety we provide.”

The French Medical Institute for Mothers and Children (FMIC) in Kabul is the first hospital in Afghanistan to receive the SafeCare certification. The facility is managed by AKU.

While acknowledging the tireless efforts and dedication of the FMIC team, CEO Aziz Ahmad Jan termed SafeCare certification as a reward for the high-quality healthcare services being offered by FMIC over the past 16 years. “This is not the end, rather the beginning of a new journey for FMIC as an innovator, a role model and a source of knowledge that raises the standard of care and professionalism within FMIC and other health facilities in Afghanistan and beyond,” he said.

Speaking on what it means to receive the accreditation, Syed Nadeem Husain Abbas, Chief Executive Officer of AKHS, Pakistan commented, “We are very excited about receiving the SafeCare certification, as it brings us one step closer to the level of excellence in healthcare that we believe our communities need and which we aspire to deliver. Our aim now is to take the quality of our health services to the next level and to inspire other hospitals and medical centres in Pakistan to do the same.”

AKU and AKHS, both agencies of the Aga Khan Development Network (AKDN), work hand-in-hand to deliver high-quality health services across Pakistan. In addition to the main hospital in Karachi, AKU operates four secondary hospitals, as well as 290+ clinical laboratories and medical centres throughout the country. To further extend this network, AKHS operates 113 health facilities, including two comprehensive medical centres, across Pakistan.

“We are committed to providing patient safety and quality healthcare. With the addition of four hospitals in Pakistan and Afghanistan, the number of SafeCare-certified facilities in the AKDN health system has reached 38, including 34 medical centres in Kenya and Tanzania,” said Dr ZeenatSulaiman, Global Head of Quality, Clinical Programs and Projects at AKHS.

Poor healthcare in low- and middle-income countries leads to millions of preventable deaths each year. However, these countries historically have a shortage of institutions that rate, improve and incentivize healthcare quality. This is the gap where SafeCare steps in to intervene and innovate.

PharmAccess CEO Nicole Spieker welcomed the newly SafeCare-certified hospitals in Pakistan and Afghanistan.

“For better patient care and safety, PharmAccess will continue to expand and scale its SafeCare program to support healthcare facilities offering primary, secondary, and tertiary healthcare in different regions. The Aga Khan hospitals have demonstrated that with dedication, quality of care is possible everywhere,” she said.

Treatment of Women’s Cancers Prioritized through Roche and Greenstar Collaboration

Karachi – Breast Cancer, Cervical and Ovarian Cancers remain the leading cause of mortality among women in Pakistan. The increasing burden of Women’s Cancers was discussed with Azra Pechuho, Sindh Health Minister during the launch of Roche and Greenstar pilot project that aims to design, develop and demonstrate scalable service delivery models that improve access to screening, early detection and treatment of Women’s Cancers.

The project, which is starting from Karachi and Lahore, will target women of different age groups and stages of patient journey, by providing door-to-door awareness, free of cost screening and guidance for timely referral options by trained doctors at Greenstar clinics.

Azra Pechuho, Sindh Health Minister, while formally launching the project said, “Providing standard of care treatment for Women’s Cancers is a priority for the Sindh government. We are proud of the Roche and Greenstar collaboration for raising awareness, early detection facilities and timely treatment of Breast, Cervical and Ovarian Cancers for women from the underserved areas of Safoorah Goth.”

Speaking at the occasion, Hafsa Shamsie, the Managing Director of Roche Pharma said, “Women face barriers at every stage of their disease journey, and this initiative is part of Roche Pakistan’s broader vision of prioritizing ‘Women’s Health’ by addressing the disparities that prohibit women from receiving appropriate care.”

“We aspire to provide innovative healthcare and play a transformative role in all stages of female cancers, from initial screening through support during treatment that paves the way for addressing the unmet needs of women cancer patients,” said Hafsa Shamsie further.

Dr. Syed Azizur Rab, CEO Greenstar Social Marketing said at the occasion, “We are very proud to partner with Roche in implementing the first of its kind community outreach program where women in catchment areas will receive free screening services and referred for further assessment”.

Breast, Cervical and Ovarian Cancers are the most common form of cancers among women in Pakistan, and early diagnosis makes these cancers treatable.

Pakistan has the highest incidence of Breast Cancer in Asia, with 25,000 cases in 2020 and a mortality rate of above 50%. Cervical Cancer is the second most common cancer in Pakistani women. Each year, around 5000 women are diagnosed with cervical cancer, with 3197 reported deaths and a mortality rate of above 63%. Similarly, 4500 Pakistani women are diagnosed with Ovarian Cancer with a mortality rate of 70%. This high prevalence stems from a lack of awareness, stigma, unaffordability, inadequate infrastructure, and distance to screening sites.

Cancer puts a huge financial burden on the families while affecting them both emotionally and psychologically. The initiative aims to align the stakeholders to increase awareness about Women’s Cancers, the importance of early detection and availability of affordable treatment.

The screening services will be provided at Greenstar’s Safoora Goth Clinic in Karachi, which was formally inaugurated today by Dr. Talib Lashari Technical Advisor, Sindh Population Welfare Department.

Martin Dow at CPHI PHARMA Awards 2022 Frankfurt, Germany

Martin Dow has been selected as the finalist and is proud to present Pakistan at the upcoming CPHI PHARMA Awards 2022 to be held in Frankfurt, Germany.

The CPHI Pharma Awards recognize excellence and celebrate cross-industry innovation in the pharmaceutical industry. This year, CPHI accepted entries from global companies engaged in the design, development, manufacture, and production of large and small-scale drug products.

Martin Dow believes in creating distinction for everyone, and that has pushed us to be at the forefront of corporate social responsibility (CSR) initiatives. Our selection as a finalist in the sustainability category of the CPHI Pharma Awards 2022 gives a true representation of our core values of bringing true welfare to society.

The awards follow strict criteria in this category and consider implementation for impact, achievements with high success rates, positive outcomes for stakeholders, and course of action and the future possibility of continued stronger impact. We at Martin Dow are proud to have successfully conformed to it and hope to keep excelling always.

Martin Dow bleeds green to save lives

Karachi: Martin Dow, a leading multinational pharmaceutical company of Pakistan commenced the 75th year of the country’s independence with a cause to save lives by carrying out a blood donation drive in collaboration with Indus Hospital.

Blood shortages are particularly acute in developing countries across much of the subcontinent, and Pakistan is no exception. Adequate and reliable supply of safe blood can only be assured through a stable base of regular, voluntary, and unpaid blood donors.

The primary goal was to facilitate the patients with blood donations for surgery, chronic illnesses, cancer treatment, and transfusions for blood loss from traumatic injuries. The donation drive was efficiently managed at Martin Dow Group Corporate Office starting from 9:30 am to 5:00 pm.

Expressing his views about these camps, Shahrukh Masood, Group Director HR & Corp Comms, said, ‘Martin Dow believes that the opportunity marks a true test of leaders’ commitment to save lives and accelerate progress towards health care for all in our lifetime. The leadership has realized that their commitment to safety is higher than ever. A single bottle of blood can save 13 lives. Every donation makes a difference. Not only is this cause necessary, but also more important as it enhances social solidarity. It sends a powerful message of mutual aid, civic commitment and social buy-in to Health for All. For healthy adults, blood donation is not only safe, but provides a sense of belonging and pride, as well as a free health check-up.’

Highlighting the need for an adequate and reliable supply of safe blood, Shahrukh Masood stressed on the importance of raising awareness for safe blood and blood products for transfusion. The theme ‘Bleed Green’ was selected to highlight the critical contribution that unpaid blood donors make to national health systems, and to promote solidarity in voluntary blood donations.

Martin Dow rolled out a complete program for the volunteers to review the guidelines before, during, and after the blood donation, such as being mindful of hydration, eating healthy food, getting enough sleep, avoiding rigorous physical activity, and skipping smoking at least 30 minutes before and after the donation.

Pak-Qatar Family Takaful (PQFTL) Signed MOU with Sehat Kahani

Karachi, June 21, 2022: Pak-Qatar Family Takaful Limited (PQFTL) came into an MOU with Sehat Kahani, to promote Takaful products through the digital medium. Sehat Kahani and PQFTL aim to make Takaful products, affordable, and accessible for the major part of the population currently not being served.

Mr. Azeem Iqbal Pirani (CEO, PQFTL), Dr. Sara Saeed Khurram (CEO, Sehat Kahani), Mr. Zeeshan Haider (Head of Alternate distribution & Banca Takaful) and Dr. Iffat Zafar (COO, Sehat Kahani) signed the MOU along with senior officials of both companies.

On the occasion, Mr. Azeem Iqbal Pirani (CEO, PQFTL) said “We are delighted to sign MOU with Sehat Kahani as this will benefit customers from choosing quality healthcare services for the low-income population of Pakistan. The world is moving towards digital medium and partnership with Sehat Kahani will further enhance our reach and help us spread awareness about Takaful products.”

Dr. Sara Saeed Khurram (CEO, Sehat Kahani) said, “Sehat Kahani’s mobile and web-based application is a holistic digital health solution that enables individuals to access primary and secondary healthcare services online without the hassle of waiting for long hours at a physical healthcare facility. That’s why we are one-stop solution for all your health problems.” She further said Pak-Qatar Takaful is the leading Takaful coverage provider in Pakistan and a trustworthy name for settling claims against losses. We are glad that our customers will be able to avail Takaful coverage on real-time basis. I am quite hopeful that this new strategic partnership will bring fruitful results in the near future.

Martin Dow Marker Ltd. joins hands with Dawaai for ‘Patient Safety’ and ‘Access of Medicines’

KARACHI April 08, 2022: Pakistan’s leading pharmaceutical company Martin Dow Marker Ltd. (MDM) signed a Memorandum of Understanding with a leading Online Pharmacy of Pakistan i.e., “Dawaai” for Joint Patient Awareness, Access & Care (JPAAC) program.

The purpose behind this strategic collaboration is to increase patients’ awareness on disease and dosage compliance and the dissemination of reliable information to cater to the health issues of the public using the digital channels and reaching out to a greater number of patients. To achieve this objective, both companies agreed on organizing and facilitating pharmacist training programs, pharmacy management skills trainings and educational awareness sessions to improve their capabilities in counselling the patients and to improve the access of medicines to the public. Through this collaboration Martin Dow Marker will support the patients in providing its quality medicines at their doorstep utilizing E-Commerce platform and the efficient network of Dawaai.

Speaking on the occasion Group Managing Director and CEO, Martin Dow, Javed Ghulam Mohammad said, “We are consistently working towards patient safety, awareness and access of our medicines and this strategic collaboration with Dawaai will strengthen our vision of reaching out to masses through digital mediums.”

While also talking at the occasion Founder & CEO, Dawaai, Furquan Kidwai, expressed his views that this is just the beginning of collaboration with Dawaai and more initiatives will continue for greater good of patients and quality health service for the entire country.

PITB, UHS sign Contract to develop ‘Post Graduate Monitoring System’

Lahore: 23 Feb 2022

Punjab Information Technology Board (PITB) and University of Health Sciences (UHS) Lahore on Wednesday signed a contract to develop the “Post Graduate Monitoring System (PGMS)” during an event held at the university campus in Lahore. The contract was signed by PITB Chairman Muhammad Asif Balal Lodhi and UHS Vice Chancellor (VC) Professor Javed Akram on behalf of their respective organisations.

The ‘Post Graduate Monitoring System’, will digitize the monitoring of PGs educational progress at designated colleges to improve quality of monitoring and transparency. The PGMS will also track students’ progress towards graduation as well as help the UHS plan their educational activities every semester and improve communication between the administration and students.

On the occasion, PITB Chairman Muhammad Asif Balal Lodhi said, “We are working on various projects with the Punjab Government, specifically the Specialized Healthcare Department. In this regard, work has already started on the PGMS project which will be completed soon.”

UHS VC Professor Javed Akram stated that a portal will be developed for better monitoring of clinical programs of MS, MD and MDS. “More than 3,000 trainees and their supervisors will be registered on the portal, through which the performance of trainees will be reviewed at every stage,” he added.

He further said that it is the first joint venture of UHS with PITB and we will continue to work with them in future. “The effort is to create systems that benefit patients,” he added. PITB Director Nausheen Fayyaz, UHS Pro-Vice Chancellor Prof. Maroof Aziz and UHS Director Medical Education Dr. Khalid Rahim were also present on the occasion.

Getz Pharma Launches ‘MEDACE’, an online learning platform for medical professionals

Getz Pharma, in collaboration with Dow University of Health Sciences (DUHS), has announced the launch of the first three courses on their brand new online medical learning platform MEDACE.

‘MEDACE’ is an initiative by Getz Pharma aimed to facilitate medical professionals acquiring access to certified online courses. The online platform is designed to enhance and improve their knowledge and practice, and aims to become the one platform for medical community where they can learn from the CME courses, watch webinars and videos as well as read blogs on recent medical updates to enhance their medical knowledge. Medical professionals can sign up for any number of certified courses throughout the year.

The launching ceremony was addressed by Dr. Jahanzeb K. Khan, Director Medical Affairs, PV and Clinical Research, Getz Pharma; Dr. Shahid Shamim, Professor of Surgery & Additional Director, Dow Institute of Health Professional Education; Dr. Yousuf Kamal Mirza, Consultant Physician & Hon. Professor of Medicine at Aga Khan University Hospital, Tabba Heart Institute & Medi-link Clinics; Prof. Bader Faiyaz Zuberi, Dean Medicine & Allied Sciences, DUHS.

Speakers from Getz Pharma and DUHS appreciated the collaborative efforts that have made this platform a reality. Doctors lauded the efforts of Getz Pharma in initiating this service, which will enable the medical fraternity across Pakistan to gain access to new and improved treatments, medical innovations and disease information.

Dr. Jahanzeb Kamal, said that MEDACE will connect young doctors with experienced ones in order to share knowledge to improve the practice via CME Courses; Webinars Lecture; Videos; Articles & Blogs. “Getz Pharma has taken scientific initiatives to develop locally accredited learning courses in collaboration with Dow University of Health Sciences, Karachi.  These courses have indigenous contents delivered by native experts covering local unmet medical educational needs”, he added.

The purpose of this initiative is to enable healthcare professionals to learn and adopt various approaches towards treating their patients. Identifying risk factors and differentiating patient symptoms for better treatment outcomes and optimizing patient care and importantly providing healthcare professionals a platform where they can develop courses for young doctors so that they can enhance their knowledge and experience with local experts.

As a research-driven pharmaceutical company, Getz Pharma takes an active role in supporting healthcare professionals. Getz Pharma is proud to launch this online learning platform MEDACE, which will serve as a tool for learning and collaboration within the medical fraternity. The first three courses were developed with the help of DUHS.

Avanceon Group to Setup Industrial Data Center at $1 Million

Avanceon Group of Companies has secured a high value five-year contract to setup and maintain industrial data center infrastructure for one of the largest FMCG corporations in Pakistan.

The project valued at $1 million to be executed by Avanceon Group of Companies digital arm Octopus Digital Limited.
The FMCG giant manufactures, stores, packages, and ships snack food products. Avanceon Group has previously worked on several projects with the customer successfully and the acquisition of this project was a result of its track record and expertise in Data Centre Management and Security.

The project holds critical value for the customer as Octopus Digital will be responsible for the Migration, Integration, Setup, and Security of the Data Center Infrastructure. It will provide all services in accordance with the Set Standard Industry Protocols.

For the execution of this project, it will be partnering with World Class OEMs. All necessary studies will be carried out before the start of the project with failsafe plans to address any safety, quality, and environmental issues.
The name of the customer company has been kept confidential as part of the Non-Disclosure Agreement.

Exit mobile version